Neonatal alloimmune thrombocytopenia (NAIT)
Platelet FMAIT, ICH risk · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
NAIT results from maternal alloantibodies (most often anti-HPA-1a) crossing the placenta and destroying fetal/neonatal platelets, in a mother with a normal platelet count. It is the platelet equivalent of rhesus disease, can occur in a first pregnancy, and carries a significant risk of intracranial haemorrhage, so severe thrombocytopenia is treated urgently.
Red flags
- Any intracranial haemorrhage on imaging or seizures/bulging fontanelle
- Platelets <30 x10^9/L or active bleeding
- Petechiae, purpura or mucosal bleeding
- Rapidly falling count
- Preterm infant with severe thrombocytopenia
Assessment
Differential diagnosis
- Maternal autoimmune thrombocytopenia (ITP) passing antibody
- Congenital/early-onset sepsis (including TORCH)
- Disseminated intravascular coagulation
- Congenital thrombocytopenia syndromes (TAR, Wiskott-Aldrich, Fanconi)
- Birth asphyxia/placental insufficiency
- Inherited/metabolic causes
Investigations
- FBC with platelet count (often <50, may be <20) and blood film
- Cranial ultrasound to exclude intracranial haemorrhage
- Maternal and paternal HPA genotyping and maternal anti-HPA antibody screen
- Coagulation screen and sepsis screen (exclude mimics)
- Repeat platelet counts to track nadir (typically days 2-5)
- Confirm maternal platelet count is normal (distinguishes from ITP)
Management
- Recognise severe isolated thrombocytopenia in an otherwise well term baby as possible NAIT
- Perform urgent cranial ultrasound to look for intracranial haemorrhage
- Send maternal/neonatal samples for HPA typing and antibody confirmation but do not delay treatment for results
- Transfuse platelets urgently for very low counts or any bleeding — HPA-compatible (e.g. HPA-1a/5b-negative) platelets are ideal
- If compatible platelets are unavailable, give random-donor platelets without delay — they still raise the count
- Give IVIG for ongoing/refractory thrombocytopenia
- Set transfusion thresholds higher than usual given ICH risk (see drugs)
- Avoid intramuscular injections and traumatic procedures until count is safe
- Monitor platelet counts closely until recovery
- Counsel parents and arrange fetal medicine planning for future pregnancies (antenatal IVIG)
Drugs & doses
HPA-compatible (or random-donor if unavailable) platelets 10-20 mL/kg IV for severe thrombocytopenia/bleeding
IV immunoglobulin 1 g/kg/day for 1-2 days (or 0.4-0.8 g/kg/day regimens) for refractory cases
Transfusion thresholds: platelets <30 x10^9/L if asymptomatic, <50 if unwell/preterm, maintain >100 if intracranial haemorrhage
Avoid IM vitamin K formulation if feasible pre-treatment (use alternative route per local policy)
Disposition
Admit to neonatal unit; urgent platelet transfusion/IVIG and cranial imaging. Haematology and fetal-medicine referral for the family's future pregnancies.
Complications & pitfalls
- Intracranial haemorrhage (antenatal or postnatal) with neurodisability
- Other major haemorrhage
- Recurrence in subsequent pregnancies, often more severe
- Transfusion-related complications
- Death from ICH
Exam pearls
- NAIT occurs in a mother with a NORMAL platelet count — this distinguishes it from maternal ITP
- Do not withhold random-donor platelets waiting for HPA-matched units if the baby is bleeding or profoundly low
- Can affect a first pregnancy and recurs (more severely) in later ones — refer to fetal medicine
- Target a higher platelet count than usual because of the disproportionate ICH risk
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.